The data have been obtained from the Heme Oxygenase Database (HemeOxDB) and refined according to the 2D-QSAR requirements. These data provide information about a set of more than 380 Heme Oxygenase-1 (HO-1) inhibitors. The development of the 2D-QSAR model has been undertaken with the use of CORAL software using SMILES, molecular graphs and hybrid descriptors (SMILES and graph together). The 2D-QSAR model regressions for HO-1 half maximal inhibitory concentration (IC50) expressed as pIC50(pIC50=â LogIC50) are here included. The 2D-QSAR model was also employed to predict the HO-1 pIC50values of the FDA approved drugs that are herewith reported.
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors
Amata Emanuele
;Marrazzo Agostino;Dichiara Maria;Modica Maria Nunziata;Salerno Loredana;Prezzavento Orazio;Nastasi Giovanni;Rescifina Antonio;Romeo Giuseppe;Pittalà Valeria
2017-01-01
Abstract
The data have been obtained from the Heme Oxygenase Database (HemeOxDB) and refined according to the 2D-QSAR requirements. These data provide information about a set of more than 380 Heme Oxygenase-1 (HO-1) inhibitors. The development of the 2D-QSAR model has been undertaken with the use of CORAL software using SMILES, molecular graphs and hybrid descriptors (SMILES and graph together). The 2D-QSAR model regressions for HO-1 half maximal inhibitory concentration (IC50) expressed as pIC50(pIC50=â LogIC50) are here included. The 2D-QSAR model was also employed to predict the HO-1 pIC50values of the FDA approved drugs that are herewith reported.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S2352340917304675-main.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Dimensione
376.72 kB
Formato
Adobe PDF
|
376.72 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.